FDA Inspection 1145751 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3002793370

The FDA completed an inspection of Biomat USA, Inc. on July 7, 2021 in Wichita Falls, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 7, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Wichita Falls, TX (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs